CellSpring is a biotech company and spinoff of the ETH Zurich. Our fully automated 3D Bloom® Biopolymer Platform dramatically increases the physiological relevance of in vitro cell-based assays.

 

Our focus is value creation. Our goal is to foster development of the next generation of great clinical tools.

As Featured In:

Chris Millan named to 2 categories: "Science & Healthcare" and "Dorm Room Founders" CellSpring hosted a booth and live talks at SLAS 2017 in Washington D.C.: "Automated Compound Screening in 3D Culture with CellSpring"
CellSpring partners with Tecan in order to automate 3D Bloom technology on Tecan liquid handling platforms CellSpring wins Heuberger Entrepreneur competition, awarded 150K
Tecan journal article highlights how CellSpring's 3D cell culture platform is automated with Tecan liquid handling platforms
CellSpring wins Venture Kick 2015, a competition for Swiss spin-off companies Bilan Magazine names CellSpring to their list of "Top 50 most investable startups in Switzerland," 2016 Swiss startup monitor startup.ch names CellSpring to "The Best Swiss Startups 2016"
As a Semifinalist, CellSpring placed in the top 10% of the Oxrbrige OneStart competition. 3D Bloom technology was developed from research conducted at ETH Zurich
CellSpring places Top 10 out of 239 business ideas submitted, awarded 2500CHF
In partnership with swissnex Boston, Venture Leaders travelled to Boston and New York for business development.

 

©2017. CellSpring. All Rights Reserved.